| RS398123259 |
IDUA
|
Health Risk |
Pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS398123260 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Hurler syndrome |
| RS398123262 |
SGCB
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Primary dilated cardiomyopathy |
| RS398123263 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Qualitative or quantitative defects of beta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS398123264 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS398123265 |
MTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS398123267 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS398123268 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS398123270 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS398123271 |
MTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123272 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS398123273 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS398123274 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Centronuclear myopathy |
| RS398123275 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS398123276 |
MMUT
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS398123278 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic acidemia |
| RS398123279 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS398123280 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS398123281 |
NAGLU
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS398123283 |
NDP
|
Health Risk |
Pathogenic/Likely pathogenic |
Atrophia bulborum hereditaria, Atrophia bulborum hereditaria |
| RS398123284 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS398123285 |
NPHP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Joubert syndrome with renal defect |
| RS398123286 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS398123287 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS398123288 |
OCRL
|
Health Risk |
Pathogenic |
— |
| RS398123289 |
OCRL
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS398123290 |
OCRL
|
Health Risk |
Pathogenic |
— |
| RS398123292 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS398123294 |
PAH
|
Health Risk |
Pathogenic |
— |
| RS398123295 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS398123296 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS398123297 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS398123298 |
PDE6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 40, Autosomal recessive retinitis pigmentosa |
| RS398123299 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS398123300 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS398123301 |
PEX12
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder type 3B |
| RS398123302 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder type 3B, Peroxisome biogenesis disorder 3A (Zellweger) |
| RS398123303 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS398123305 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS398123306 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS398123307 |
PKD2
|
Health Risk |
Likely pathogenic |
— |
| RS398123308 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS398123309 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS398123310 |
PMM2
|
Health Risk |
Likely pathogenic |
— |
| RS398123311 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS398123312 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, Inborn genetic diseases |
| RS398123313 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS398123314 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, Hepatocellular carcinoma |
| RS398123316 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS398123317 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS398123318 |
PTEN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cowden syndrome 1 |
| RS398123320 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS398123321 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome 1 |
| RS398123322 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS398123323 |
PTEN
|
Health Risk |
Pathogenic |
Macrocephaly-autism syndrome, Hereditary cancer-predisposing syndrome |
| RS398123324 |
PTEN
|
Health Risk |
Likely pathogenic |
Colorectal cancer, Hereditary cancer-predisposing syndrome |
| RS398123325 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS398123328 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS398123329 |
PTEN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cowden syndrome |
| RS398123330 |
PTEN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome |
| RS398123331 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS398123332 |
RB1
|
Health Risk |
Pathogenic |
— |
| RS398123333 |
RB1
|
Health Risk |
Pathogenic |
— |
| RS398123338 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS398123339 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Central scotoma |
| RS398123341 |
MID1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS398123342 |
MID1
|
Health Risk |
Likely pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS398123343 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS398123347 |
GLB1
|
Health Risk |
Likely pathogenic |
— |
| RS398123348 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS398123349 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS398123350 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS398123351 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS398123353 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS398123354 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS398123355 |
GLB1
|
Health Risk |
Conflicting classifications of pathogenicity |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS398123356 |
GLB1
|
Health Risk |
Pathogenic |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS398123357 |
GLB1
|
Health Risk |
Conflicting classifications of pathogenicity |
GM1 gangliosidosis type 3, GM1 gangliosidosis type 2 |
| RS398123358 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, GM1 gangliosidosis |
| RS398123360 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS398123361 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS398123362 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS398123363 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS398123364 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS398123367 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS398123368 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Muscular dystrophy |
| RS398123369 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123371 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123372 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS398123373 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123374 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of esophagus, Familial cancer of breast |
| RS398123375 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123377 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123378 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123379 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS398123380 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS398123381 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123382 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS398123383 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Elevated circulating creatine kinase concentration |
| RS398123385 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |